source
- AstraZeneca’s heart drug Wainua fails late-stage trial, raising 2027 outlook concernsAstraZeneca announced that its experimental heart disease therapy, Wainua, did not meet primary endpoints in a Phase III trial conducted in July. The failure is a setback for the company, whose pi…
- Pfizer shuts India cancer drug plant for up to two years, worsening drug shortagesPfizer has temporarily closed a manufacturing site in India that produces several cancer medicines. The company says the facility will remain idle for as long as two years while it addresses the i…